Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat

Sofola, Oyinkan, Jin, Peng, Botas, Juan and Nelson, David (2007) Argonaute-2-dependent rescue of a Drosophila model of FXTAS by FRAXE premutation repeat. Human Molecular Genetics, 16 (19). pp. 2326-2332. ISSN 0964-6906

[img] PDF - Published Version
Restricted to SRO admin only

Download (629kB)
Official URL: https://doi.org/

Abstract

Fragile X Syndrome is the most common form of hereditary mental retardation. It is caused by a large expansion of the CGG trinucleotide repeat (>200 repeats) in the 5′-untranslated region (UTR) of the FMR1 gene that leads to silencing of its transcript. Individuals with CGG repeat expansions approximately between 60 and 200 are referred to as premutation carriers. Fragile X-associated tremor and ataxia syndrome (FXTAS), an RNA-mediated neurodegenerative disease has been described in up to 50% of males carrying premutation alleles. FRAXE, the most common form of non-syndromic X-linked mental retardation, is caused by expansion of a CCG trinucleotide repeat (>200) in the 5′-UTR of the FMR2 gene. While the FRAXE premutation length repeat is observed in the general population, there has not yet been a report of a neurodegenerative phenotype associated with these alleles. In this study, we show that the CCG premutation length repeat leads to an RNA-mediated neurodegenerative phenotype in a Drosophila model. Furthermore, we show that co-expression of both the CCG and CGG-containing RNAs suppresses their independent toxicity and is dependent on the RNAi pathway. These data support the concept that RNA toxicity is the mechanism of neuronal toxicity and suggests potential reversal of RNA-mediated phenotypes with complementary RNA molecules.

Item Type: Article
Schools and Departments: School of Life Sciences > Neuroscience
Depositing User: Oyinkan Adesakin
Date Deposited: 02 Nov 2017 10:08
Last Modified: 02 Nov 2017 10:08
URI: http://sro.sussex.ac.uk/id/eprint/70855

View download statistics for this item

📧 Request an update